Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,535.80
Bid: 1,538.80
Ask: 1,539.60
Change: -34.00 (-2.17%)
Spread: 0.80 (0.05%)
Open: 1,560.00
High: 1,564.60
Low: 1,529.80
Yest. Close: 1,569.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

MidaTech Pharma Appoints Frederic Duchesne As Non-Executive Director

Wed, 31st Jul 2019 15:54

(Alliance News) - Midatech Pharma PLC said Wednesday that Frederic Duchesne had been appointed as a non-executive director, effective immediately.

Duchesne was chief executive of the pharmaceuticals division of Pierre Fabre Laboratories until May. In addition to his nine-year stint with Pierre Fabre, Duchesne has held senior position with French drug firm Sanofi SA, the UK's GlaxoSmithKline PLC and the US's Bristol-Myers Squibb Co.

"I look forward to working with Frederic and am very confident he will make an important and positive impact to Midatech across the business, particularly with the next, important stage in developing our manufacturing capabilities and commercialising the company's assets, as the company continues to develop its key projects through their clinical phase and towards their successful launch," said Midatech Chair Rolf Stahel

Shares in Midatech were trading 0.1% higher at 6.88 pence each on Wednesday in London.

More News

UPDATE: UK Inks Deals For 90 Million Doses Of Potential Covid Vaccines

UPDATE: UK Inks Deals For 90 Million Doses Of Potential Covid Vaccines

14 Aug 20 11:27

LONDON MARKET CLOSE: FTSE 100 Lags As Brexit Worries Return

LONDON MARKET CLOSE: FTSE 100 Lags As Brexit Worries Return

13 Aug 20 16:56

LONDON MARKET MIDDAY: FTSE 100 Sinks As Ex-Dividend Shares Drag

LONDON MARKET MIDDAY: FTSE 100 Sinks As Ex-Dividend Shares Drag

13 Aug 20 12:22

UK WINNERS & LOSERS SUMMARY: Covid-19 Hit Sends National Express Lower

UK WINNERS & LOSERS SUMMARY: Covid-19 Hit Sends National Express Lower

13 Aug 20 11:02

LONDON MARKET OPEN: Watches Of Switzerland Ticks Along Nicely

LONDON MARKET OPEN: Watches Of Switzerland Ticks Along Nicely

13 Aug 20 09:00

LONDON MARKET CLOSE: Housebuilders Boost FTSE 100 Despite GDP Plunge

LONDON MARKET CLOSE: Housebuilders Boost FTSE 100 Despite GDP Plunge

12 Aug 20 16:56

UK BROKER RATINGS SUMMARY: Davy Cuts IAG To Neutral From Outperform

UK BROKER RATINGS SUMMARY: Davy Cuts IAG To Neutral From Outperform

12 Aug 20 09:09

Ideagen Trades In Line With Forecasts; Buys Qualsys For GBP16 Million

Ideagen Trades In Line With Forecasts; Buys Qualsys For GBP16 Million

10 Aug 20 10:12

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

6 Aug 20 16:05

Goldman Sachs thinks markets underpricing odds for Covid-19 vaccine before year end

(Sharecast News) - Goldman Sachs thinks the world will be in a very different place in three months' time on at least three front, so much so that investors' expectations for the outcomes will likely set the tone for trading until then.

6 Aug 20 15:23

GSK receives FDA approval for blood cancer drug

(Sharecast News) - Pharmaceutical giant GlaxoSmithKline has received approval from the US Food and Drug Administration for the use of belantamab mafodotin-blmf (BLENREP) in the treatment of patients with relapsed or refractory multiple myeloma.

6 Aug 20 08:02

TOP NEWS: US Regulator Approves Glaxo's Blenrep As Myeloma Treatment

TOP NEWS: US Regulator Approves Glaxo's Blenrep As Myeloma Treatment

6 Aug 20 05:42

WHO warns 'silver bullet' for Covid-19 may never come

(Sharecast News) - The World Health Organization warned on Monday that there is a possibility that a "silver bullet" to combat Covid-19 may never come despite the existing strong hopes for a vaccine.

3 Aug 20 13:01

Sanofi under investigation on charges including manslaughter

(Sharecast News) - Healthcare company Sanofi Aventis France said on Monday that it had been placed under investigation for charges, including manslaughter.

3 Aug 20 11:26

LONDON MARKET PRE-OPEN: Glaxo And Sanofi Set To Supply Vaccine For EU

LONDON MARKET PRE-OPEN: Glaxo And Sanofi Set To Supply Vaccine For EU

3 Aug 20 07:50

Login to your account

Don't have an account? Click here to register.